Lumida
/HRL
⌘K
Hormel Foods Corp

Hormel Foods Corp

HRL
$25.39USD-1.24%-0.32 today

MARKET CAP

14.0B

P/E (TTM)

18.0x

FWD P/E

16.5x

DAY RANGE

$25 – $26

52W RANGE

$20
$30

AI Summary

Stalk
Buy NowMedium

HRL remains in a Stage 2 advancing regime with bullish medium-term structure supported by rising EMAs and a clear series of higher highs and higher lows since mid-year. Recent pullback into the rising 9 and 20 EMAs, while price holds above the 50 DMA, offers a favorable execution window. Despite the long-term downtrend, the medium-term bullish bias is intact, and short-term timing conditions support immediate participation on the pullback. Caution remains around overbought context and clustering exhaustion signals at the recent peak.

  • Q2 organic net sales rose 3% YoY to $2.97 billion
  • Adjusted EPS grew 14% YoY to $0.40
  • Weak profitability factors as input costs compress margins
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Hormel Foods Corporation (NYSE: HRL) is a leading global branded food company that primarily focuses on protein-centric products. The company operates across various segments, including retail (where they offer popular brands like SPAM, Jennie-O, and Applegate), food service, and international markets. Hormel has a strong brand presence and continually innovates to meet evolving consumer preferences for convenient and healthy food options. As a key player in the consumer packaged goods industry, Hormel is strategically positioned to navigate market dynamics amid rising input costs and changing consumer behaviors.

Bull says

  • Q2 organic net sales rose 3% YoY to $2.97 billion
  • Adjusted EPS grew 14% YoY to $0.40
  • Gross margin expanded to 17.4% despite headwinds
  • $827 million cash and low leverage support growth initiatives
  • Strong earnings yield and insider buying signal confidence
  • 60-year dividend growth record with 1.49% yield

Bear says

  • Weak profitability factors as input costs compress margins
  • Full-year EPS estimates cut; earnings revisions remain negative
  • Retail organic net sales fell 2% after private-label exits
  • Commodity inflation and logistical inefficiencies pressure margins
  • Cautious consumer sentiment may dent protein demand
  • Negative profitability and growth factors underscore downside risk

Investment themes with HRL

High Dividend Yield +0.32%

Companies paying above-average dividends

AVGO · JPM · XOM

Earnings Call · Q2 2025 · Mgmt. Guidance

Updated 05-28-2026neutral

Transcript signals

Bull points

  • We achieved solid organic top line growth and delivered second quarter results in line with our expectations, demonstrating our commitment to delivering profitable and predictable growth.
  • we continue to hold leadership positions in the marketplace across our diverse portfolio, indicating our success with both consumers and customers creating a stable and reliable brand they can trust.
  • I want to highlight three areas of the retail portfolio that really brought this to life. The Applegate brand is well aligned with today's consumer demand for convenient protein solutions, experiencing incredible sales growth, outpacing the total edible category.

Bear points

  • we expect half one and half two results will look very different.
  • In the face of an evolving backdrop, we are responsibly narrowing our fiscal 2025 outlook, which remains largely unchanged. For the full year, we now expect increased net sales growth of 2 to 3%, taking into account current views on the consumer, tariffs, and lower investment income.
  • I would describe the consumer sentiment as positive, not great, meaning they're feeling the cumulative effects of inflation and at the same time feeling uncertainty in the macro environment. So I would describe that as a strained consumer sentiment.
Read full transcript analysis ›